Sign in

CIK 0001599298

  • Large accelerated filer

Summit Therapeutics Inc.

Sign in to watch
Ticker
SMMT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
371979717
Phone
+1 305-203-2034
Business address
601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
Former names
Summit Therapeutics plc, Summit Corp plc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-08-16 Zanganeh Maky Co-CEO & President Purchase +184,430 $0.97 $179K 359,969
2022-08-16 Zanganeh Maky Co-CEO & President Purchase +4,593,777 $0.97 $4.5M 7,061,557
2022-08-16 Zanganeh Maky Co-CEO & President Purchase +1,030,925 $0.97 $1000K 3,135,466
2021-12-15 Zanganeh Maky Chief Operating Officer Grant or award · Stock Option (right to buy) +15,000 15,000
2021-05-12 Zanganeh Maky Chief Operating Officer Purchase +389,077 $5.24 $2.0M 2,643,319
2020-11-22 Zanganeh Maky Chief Operating Officer Grant or award · Stock Option (right to buy) +2,400,000 3,724,499
2020-11-11 Zanganeh Maky Director Grant or award · Stock Option (right to buy) +200,000 1,321,177
2020-11-11 Zanganeh Maky Director Grant or award · Stock Option (right to buy) +3,323 1,324,500

Page 1 of 1 · 8 trades